Bio-Rad Laboratories, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 10-Q, Quarterly reportAug 4 →InsidersNo open-market buys. 2 insiders sold $349,883, 0 of 2 sales on a 10b5-1 plan.→PeersClosest companies: AZTA, MLAB, WST→
From the filings
Figures
- Revenue
- $2.59Blast 12 months
- Net income
- $222.4Mlast 12 months
- Operating cash flow
- $510.4Mlast 12 months
- Cash and equivalents
- $517.0Mat the last balance sheet
- Total debt
- $803.0Mat the last balance sheet